Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Eptinezumab in Participants With Episodic Cluster Headache

ClinicalTrials.gov ID: NCT04688775

Public ClinicalTrials.gov record NCT04688775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Delayed-Start Study to Evaluate the Efficacy and Safety of Eptinezumab in Patients With Episodic Cluster Headache

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH)

Study identification

NCT ID
NCT04688775
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
231 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 23, 2020 (Actual)
Primary completion
Jun 14, 2023 (Actual)
Completion
Oct 5, 2023 (Actual)
Last update posted
Aug 9, 2024

2020 – 2023

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
Mayo Clinic in Arizona - Phoenix Campus Phoenix Arizona 85054 —
Keck School of Medicine of USC Los Angeles California 90033 —
Clinical Research Institute Los Angeles California 90048 —
Stanford Neurosciences Health Center Palo Alto California 94304 —
Neurology Colorado - Denver Advanced Neurological Evaluation and Treatment Center Denver Colorado 80218 —
Yale New Haven Hospital New Haven Connecticut 06510-2483 —
New England Institute for Neurology and Headache Stamford Connecticut 06905 —
Accel Research Sites - Tampa Tampa Florida 33634 —
Diamond Headache Clinic Chicago Illinois 60642 —
Michigan Headache and Neurological Institute Ann Arbor Michigan 48104-5131 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
The Headache Center Mississippi Ridgeland Mississippi 39157 —
Clinvest Research Springfield Missouri 65810 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Dent Neurologic Institute - Amherst Amherst New York 14226 —
New York University School of Medicine New York New York 10016 —
Headache Wellness Center Greensboro North Carolina 27405 —
Cleveland Clinic - Neurological Institute Cleveland Ohio 44195 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
Hightower Clinical Oklahoma City Oklahoma 73134 —
Thomas Jefferson University Hospital - Center City Campus Philadelphia Pennsylvania 19107 —
Mischer Neuroscience Institute Houston Texas 77030 —
Froedtert and Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 96 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04688775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04688775 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →